top of page

Innovation Bridge Program

Eligibility and Evaluation

  • Researchers ready to spin out IP and establish a commercial entity

  • Early-stage life science companies and startups who need funding to bridge early developmental gaps

  • All applicants must be focused on company formation/growth

Funding Structure:

  • Variable, based on funding request and merit of the application 

  • Typical award size: $25,000-$100,000

Eligible use of funds:

  • Costs associated with company formation and Spin-Out from research setting

  • Direct costs including materials, supplies and equipment associated with estabishing a commercial entity/advancing early commercial milestones

  • 30% cap on idirect costs (overhead rates, staff, and rent) 

​

Application Due Date for Funding Decision

  • March 23

  • May 25

  • July 27

  • September 28

  • November 9

BOD Meeting for Funding Decision

  • April 22

  • June 24

  • August 26

  • October 28

  • December 16

Funding opportunities are open on a rolling basis and will be reviewed in accordance with the every-other month Board meetings. Applications submitted by the end of the month leading up to a Board meeting will have the opportunity to be reviewed by the Board for award.

Resources

  • View Application

  • Applicants are required to create an account prior to accessing the application. If you already have an account, please log in to begin the application.

  • This in an "Invitation Only" application - please reach out to info@rilifescience.com to request a code. 

Impact on the Ecosystem

A thriving life science industry requires key support from those who know the industry, regulations, startup pitfalls, funding landscape and more. Organizations who serve and target underrepresented populations in the life sciences have the potential to shape the Rhode Island life science industry and provide opportunities for all Rhode Islanders. RILSH is conscientious of duplication, and we ask applicants to conduct a landscape study before applying, to ensure that the applicant’s offering serve a unique and distinct need in the Rhode Island life science industry. Programs well-positioned for funding are those that focus on bridging key gaps, provide equitable access to services and programs, and focus on entities with commercialization/commercial potential.

Program Overview

The Innovation Bridge program is designed to support innovators in the life sciences by providing funding to bridge critical gaps in the technology development lifecycle. This opportunity aims to accelerate the development of cutting-edge solutions by addressing key challenges such as technology validation, regulatory navigation, market readiness, and scaling operations.

Through Innovation Bridge, selected innovators will receive financial support to advance their work toward commercialization, along with access to subject-matter experts, industry networks, and strategic resources. The program seeks to drive innovation, strengthen the life sciences ecosystem, and promote economic growth within Rhode Island.

​

Eligible applicants include researchers, startups, and early-stage companies developing novel solutions in biotechnology, pharmaceuticals, medical devices, diagnostics, and other life science fields. Funding is intended to support activities that enhance product readiness, de-risk development pathways, and attract additional investment while fostering high-impact innovation in Rhode Island.

bottom of page